Priorities and Implementation Barriers in End-to-End Digital Transformation in the Pharmaceutical Industry: Sequential Mixed Methods Analysis

Published on 09.Oct.2026 in Vol 28 (2026)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/91531, first published 16.Jan.2026.

; Adama Ibrahim²

; Baris Ersezer³

; Angela Radcliffe⁴

; Victoria Gamerman⁵

; Bert Hartog⁶

; Lars Fogh Iversen²

; Marcus Schindler²

Isaac Rogelio Rodriguez-Chavez ^{1
*} , MS, MHS, PHD ; Adama Ibrahim ^{2
*} , EMBA ; Baris Ersezer ³ , BS ; Angela Radcliffe ⁴ , EMBA ; Victoria Gamerman ⁵ , MS, MA, PHD ; Bert Hartog ⁶ , MS, PHD ; Lars Fogh Iversen ² , MS, PHD ; Marcus Schindler ² , MS, PHD

¹ 4Biosolutions Consulting, Rockville, MD, United States

² Novo Nordisk, Måløv, Denmark

³ Novartis, Basel, Switzerland

⁴ How Mighty We Ventures, Huntingdon Valley, PA, United States

⁵ RWD Insights, Stamford, CT, United States

⁶ Hartog Digital Health Consulting, Middelburg, The Netherlands

*these authors contributed equally

Corresponding Author: